FRA
Front Row Advisors’s Relmada Therapeutics RLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2 | Sell |
3
-3
| -50% | -$2 | ﹤0.01% | 538 |
|
|
2025
Q1 | $2 | Buy |
+6
| New | +$2 | ﹤0.01% | 511 |
|
|
2024
Q4 | – | Sell |
-6
| Closed | -$19 | – | 506 |
|
|
2024
Q3 | $19 | Hold |
6
| – | – | ﹤0.01% | 499 |
|
|
2024
Q2 | $18 | Hold |
6
| – | – | ﹤0.01% | 937 |
|
|
2024
Q1 | $28 | Hold |
6
| – | – | ﹤0.01% | 923 |
|
|
2023
Q4 | $25 | Hold |
6
| – | – | ﹤0.01% | 469 |
|
|
2023
Q3 | $18 | Hold |
6
| – | – | ﹤0.01% | 916 |
|
|
2023
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 942 |
|
|
2023
Q1 | $0 | Buy |
+6
| New | – | ﹤0.01% | 947 |
|